Find Funding Opportunities

The National Institute on Drug Abuse (NIDA) intends to solicit proposals from qualified organizations (NAICS Code 541715) having in-house capability to support and provide resources to the participating grantees for completing biocompatibility studies, in vivo animal testing compliant with good laboratory (GLP) guidelines, and sterilization and shelf life testing. This contractor will provide support for research protocol development, research staff training, and conduct all testing necessary to support biocompatibility, sterilization, and animal safety studies.

The National Institute on Drug Abuse (NIDA) intends to solicit proposals from qualified organizations (NAICS Code 541715) having in-house capability to support and provide resources to the participating grantees for completing clinical feasibility studies of novel medical devices in the neurotechnology field. The clinical studies may include both feasibility and larger safety and efficacy assessments in patients affected by the condition being studied. BPMT anticipates running 5 to 15 clinical studies per year over the next 5 years. Most, but not all, are likely to be NIH-defined Clinical Trials https://grants.nih.gov/policy/clinical-trials/definition.htm.

The purpose of this notice is to move the first receipt date to July 15, 2022.

This Notice modifies key dates of RFA-MH-21-180.

The purpose of this NOSI is to solicit projects on preventive interventions that address cardiometabolic risk factors in populations that experience health disparities.

The purpose of this time-sensitive Request for Information (RFI) is to solicit public input on promising progress and opportunities that have emerged in cerebral palsy (CP) research since the publication of the NINDS/NICHD Strategic Plan for Cerebral Palsy Research in 2017.

This Notice highlights the NINDSs interest in receiving grant applications focused on advancing the careers of a diverse translational research workforce in response to PAR-20-240, NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25).

This Notice is to announce the availability of an informational webinar video with overview information on program goals, application instructions, and project responsiveness for RFA-NS-22-047, RFA-NS-22-048,and RFA-NS-22-049, which are the initiating FOAs for the BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS) Program. The pre-recorded video is optional and is not required for submission of an application.

The purpose of this notice is to clarify the Eligibility Criteria for NOT-NS-21- 014 "Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination".

This Request for Information (RFI) seeks input on challenges and opportunities for interdisciplinary research that brings together neuroscientists, environmental health scientists, and scientists from other related disciplines to form new teams to advance understanding of the contribution of environmental toxicants to impaired function of the nervous system across the life span. For the purpose of this RFI, environmental toxicants of primary interest include industrial chemicals or manufacturing byproducts, metals, pesticides, herbicides, air pollutants and other inhaled toxicants, particulates or fibers, plastics, fungal exposures, and bacterial or biologically derived toxins. Expression of toxicity can take many forms across different ages and developmental stages, ranging from neurodevelopmental to neurodegenerative disorders, and encompassing alterations in cognition and behavior that range from subtle to severe. The full range of nervous system outcomes is relevant to this RFI.